within Pharmacolibrary.Drugs.ATC.A;

model A02AC10
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.77,
    Cl             = 0.0016666666666666668,
    adminDuration  = 600,
    adminMass      = 0.04,
    adminCount     = 1,
    Vd             = 0.00015,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.018333333333333333,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>A fixed combination therapy used for the eradication of Helicobacter pylori infection in peptic ulcer disease. The combination contains a proton pump inhibitor (pantoprazole) and two antibiotics (amoxicillin, clarithromycin). It is approved and used as a first-line regimen in many countries.</p><h4>Pharmacokinetics</h4><p>Estimated one-compartment model for adults receiving standard triple therapy orally. Typical PK parameters are based on literature for each component, since no published PK model exists for the fixed combination. Parameters reflect healthy adult subjects.</p><h4>References</h4><ol><li><p>Ghim, JL, et al., &amp; Shin, JG (2021). Pharmacokinetics and Pharmacodynamics of Tegoprazan Coadministered With Amoxicillin and Clarithromycin in Healthy Subjects. <i>Journal of clinical pharmacology</i> 61(7) 913–922. DOI:<a href=&quot;https://doi.org/10.1002/jcph.1805&quot;>10.1002/jcph.1805</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33341955/&quot;>https://pubmed.ncbi.nlm.nih.gov/33341955</a></p></li><li><p>Cheer, SM, et al., &amp; Lamb, HM (2003). Pantoprazole: an update of its pharmacological properties and therapeutic use in the management of acid-related disorders. <i>Drugs</i> 63(1) 101–133. DOI:<a href=&quot;https://doi.org/10.2165/00003495-200363010-00006&quot;>10.2165/00003495-200363010-00006</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/12487624/&quot;>https://pubmed.ncbi.nlm.nih.gov/12487624</a></p></li><li><p>Pilotto, A, et al., &amp; Valerio, G (2001). Cure of Helicobacter pylori infection in elderly patients: comparison of low versus high doses of clarithromycin in combination with amoxicillin and pantoprazole. <i>Alimentary pharmacology &amp; therapeutics</i> 15(7) 1031–1036. DOI:<a href=&quot;https://doi.org/10.1046/j.1365-2036.2001.01008.x&quot;>10.1046/j.1365-2036.2001.01008.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11421879/&quot;>https://pubmed.ncbi.nlm.nih.gov/11421879</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end A02AC10;
